View Full Paper

Owner Consent Verified
Case Study 4.9

Governance And Risk in Telemedicine for Pharmaceutical Firms: Post-Pandemic Lessons

15
Pages
Harvard
Style
~ 15–23 mins
Reading Time
Energy Impact FinTech
Abstract

This case study investigates “Governance And Risk in Telemedicine for Pharmaceutical Firms: Post-Pandemic Lessons” using a systematic literature review. Through a economic lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

Governance And Risk in Telemedicine for Pharmaceutical Firms: Post-Pandemic Lessons

ABSTRACT
Governance And Risk in Telemedicine for Pharmaceutical Firms: Post-Pandemic Lessons is unpacked across themes: KPIs, risks, interoperability, and usability. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
10 Pages 4.9
Robotic Process Automation and Sustainability Outcomes among NGOs in Global Health — Evidence from Europe
Governance Sustainability NLP
View Paper
31 Pages 4.6
Urban Planning for SMEs in Sub-Saharan Africa: Market Entry Strategy | A Comparative Perspective
UX InsurTech DEI
View Paper
40 Pages 4.7
Telemedicine for Logistics Hubs in Europe: Adoption Barriers | A Comparative Perspective
Food Systems Epidemiology Cold Chain
View Paper